⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

September 16, 2024

Figure S2 from Ccr2⁺ monocyte-derived macrophages influence trajectories of acquired therapy resistance in Braf-mutant melanoma

Dahihm Kim Luye An Jiwon Moon Viviana I. Maymí Alexander I. McGurk Brian D. Rudd Deborah J. Fowell Andrew C. White

View Full Paper

Ask AI

Bookmark

Share

Abstract

Representative flow cytometry plot showing gating strategies for identifying monocytes in blood and macrophages in TBP tumors.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kim et al. (2024) studied this question.

synapsesocial.com/papers/68e586b5b6db643587523274 https://doi.org/10.1158/0008-5472.27027827.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Figure S5 from Ccr2<sup>+</sup> monocyte-derived macrophages influence trajectories of acquired therapy resistance in <i>Braf</i>-mutant melanoma2024
2Figure S4 from Ccr2<sup>+</sup> monocyte-derived macrophages influence trajectories of acquired therapy resistance in <i>Braf</i>-mutant melanoma2024
3Table S1 from Ccr2<sup>+</sup> monocyte-derived macrophages influence trajectories of acquired therapy resistance in <i>Braf</i>-mutant melanoma2024
4Table S1 from Ccr2<sup>+</sup> monocyte-derived macrophages influence trajectories of acquired therapy resistance in <i>Braf</i>-mutant melanoma2024
5Figure S3 from Ccr2<sup>+</sup> monocyte-derived macrophages influence trajectories of acquired therapy resistance in <i>Braf</i>-mutant melanoma2024